Single Nuclei RNA-seq to Map Adipose Cellular Populations and Senescent Cells in Older Subjects

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 17, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2027

Conditions
ObesityHealthy Lifestyle
Interventions
OTHER

Lifestyle Intervention

"1. Exercise: Subjects will undergo a combined aerobic and resistance exercise intervention. The investigators propose a multi-modal training program because they improve metabolic outcomes and adding resistance training reduces the risk of muscle loss during weight loss. Subjects will exercise in the gym for three sessions per week for 10 weeks under supervision of an exercise physiologist. On each session, aerobic exercise will be followed by resistance exercise.~2. Diet: The aim of the dietary intervention is to reduce caloric intake sufficient to result in 8-10% weight loss, while incorporating behavioral and dietary strategies to maximize adherence and to minimize risk of muscle and bone loss. Subjects will attend small-group sessions led by a dietitian for changing their dietary composition to follow American Heart Association (AHA)/American College of Cardiology (ACC) guidelines."

DRUG

Dasatinib 100 MG

100 mg of dasatinib (D) daily for 3 consecutive days plus quercetin (Q) for the same 3 consecutive days, followed by a 25-day (+/- 2 day) no-drug period to complete a single round. This will be repeated twice more until completing 3 rounds total in approximately 10 consecutive weeks.

DRUG

Quercetin 1000mg

Quercetin (Q) (4) 250 mg capsules daily (total 1000 mg daily) plus dasatinib (D) same 3 consecutive days, followed by a 25-day (+/- 2 day) no-drug period to complete a single round. This will be repeated twice more until completing 3 rounds total in approximately 10 consecutive weeks.

DRUG

Placebo

Subjects will receive a placebo (methylcellulose) to provide a similar mass, number of tablets/ capsules, and frequency as the senolytic arm.

PROCEDURE

Abdominal adipose tissue biopsy

All participants will undergo baseline biopsies of subcutaneous abdominal adipose tissue for cellular/molecular profiling via snRNA-seq

Trial Locations (1)

90048

RECRUITING

Cedars Sinai Medical Center, Los Angeles

All Listed Sponsors
collaborator

National Institute on Aging (NIA)

NIH

lead

Cedars-Sinai Medical Center

OTHER